At Gennvax, we are thrilled to announce a significant milestone in our journey to support Egypt’s vision of localizing vaccine production. In collaboration with the Egyptian Vaccine Manufacturing Alliance (Evma), and under the patronage of the Unified Purchasing Authority we have forged strategic partnerships with two renowned global leaders in vaccine manufacturing:

Minhai from China being one of the top vaccines manufacturers in the world and AJ Vaccines from Denmark as a leader in providing innovative vaccines in Europe These partnerships mark a transformative step towards enhancing the local production of high-quality vaccines, reducing reliance on imports, and strengthening Egypt’s healthcare infrastructure.

By embracing such global collaborations, we aim to foster innovation, build sustainable technologies, and empower local capabilities in the field of vaccine production in our state of art vaccines facility Gennvax

Our mission is deeply aligned with the national agenda to ensure a healthier, more resilient future for all. This achievement reflects our commitment not only to public health but also to driving progress in biotechnology and pharmaceutical manufacturing in the while continent

Together with our esteemed partners, we are paving the way for a brighter, healthier future—one where Egypt emerges as a regional hub for vaccine production and innovation.

Together for healthier world , together for Africa

By Africans for Africans